Active Ingredient: CISATRACURIUM BESYLATE
Proprietary Name: CISATRACURIUM BESYLATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A215516
Product Number: 002
Approval Date: May 24, 2022
Applicant Holder Full Name: PIRAMAL CRITICAL CARE INC
Marketing Status:
Prescription
Patent and Exclusivity Information
